4.8 Article

Crk proteins transduce FGF signaling to promote lens fiber cell elongation

Journal

ELIFE
Volume 7, Issue -, Pages -

Publisher

ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.32586

Keywords

-

Categories

Funding

  1. National Eye Institute [EY017061, 5P30EY019007]
  2. Research to Prevent Blindness

Ask authors/readers for more resources

Specific cell shapes are fundamental to the organization and function of multicellular organisms. Fibroblast Growth Factor (FGF) signaling induces the elongation of lens fiber cells during vertebrate lens development. Nonetheless, exactly how this extracellular FGF signal is transmitted to the cytoskeletal network has previously not been determined. Here, we show that the Crk family of adaptor proteins, Crk and Crkl, are required for mouse lens morphogenesis but not differentiation. Genetic ablation and epistasis experiments demonstrated that Crk and Crkl play overlapping roles downstream of FGF signaling in order to regulate lens fiber cell elongation. Upon FGF stimulation, Crk proteins were found to interact with Frs2, Shp2 and Grb2. The loss of Crk proteins was partially compensated for by the activation of Ras and Rac signaling. These results reveal that Crk proteins are important partners of the Frs2/Shp2/Grb2 complex in mediating FGF signaling, specifically promoting cell shape changes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma

Renata E. Gordon, Li Zhang, Suraj Peri, Yin-Ming Kuo, Fang Du, Brian L. Egleston, Jessica M. Y. Ng, Andrew J. Andrews, Igor Astsaturov, Tom Curran, Zeng-Jie Yang

CLINICAL CANCER RESEARCH (2018)

Article Immunology

Crk Adaptor Proteins Regulate NK Cell Expansion and Differentiation during Mouse Cytomegalovirus Infection

Tsukasa Nabekura, Zhiying Chen, Casey Schroeder, Taeju Park, Eric Vivier, Lewis L. Lanier, Dongfang Liu

JOURNAL OF IMMUNOLOGY (2018)

Article Oncology

Leukotriene Synthesis Is Critical for Medulloblastoma Progression

Fang Du, Larra Yuelling, Eric H. Lee, Yuan Wang, Shengyou Liao, Yan Cheng, Li Zhang, Chaonan Zheng, Suraj Peri, Kathy Q. Cai, Jessica M. Y. Ng, Tom Curran, Peng Li, Zeng-Jie Yang

CLINICAL CANCER RESEARCH (2019)

Article Biochemistry & Molecular Biology

Requirement for Crk and CrkL during postnatal lens development

Taeju Park, Tom Curran

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Statins repress hedgehog signaling in medulloblastoma with no bone toxicities

Qianhai Fan, Tingting Gong, Chaonan Zheng, Jessica M. Y. Ng, Jianquan Chen, Cynthia Myers, Harvey Hensley, Tom Curran, Zeng-jie Yang

Summary: Cholesterol plays a critical role in bone development, while statins, which inhibit the Hh pathway, can be used to treat medulloblastoma without affecting bone growth.

ONCOGENE (2021)

Article Cell Biology

Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality

Mai T. Dang, Michael Gonzalez, Krutika S. Gaonkar, Komal S. Rathi, Patricia Young, Sherjeel Arif, Li Zhai, Zahidul Alam, Samir Devalaraja, Tsun Ki Jerrick To, Ian W. Folkert, Pichai Raman, Jo Lynne Rokita, Daniel Martinez, Jaclyn N. Taroni, Joshua A. Shapiro, Casey S. Greene, Candace Savonen, Fernanda Mafra, Hakon Hakonarson, Tom Curran, Malay Haldar

Summary: The study revealed significant changes in the composition of TAMs in medulloblastomas (MB) under different treatment modalities, with radiation inducing an immunosuppressive subset of TAMs. These findings highlight the important role of TAMs in tumor progression and response to therapy.

CELL REPORTS (2021)

Review Cell Biology

Crk and CrkL as Therapeutic Targets for Cancer Treatment

Taeju Park

Summary: Crk and CrkL, cellular counterparts of the viral oncoprotein v-Crk, are frequently overexpressed in human cancers and associated with poor prognosis. Gene knockdown or overexpression of Crk and CrkL can affect tumor cell functions, making them potential targets for cancer therapy. Studies suggest a comprehensive understanding of the distinct and overlapping roles of Crk and CrkL in tumor cell functions is crucial for developing effective therapeutic strategies.

CELLS (2021)

Editorial Material Medicine, Research & Experimental

A call to action: Issuing a diversity and inclusion challenge to research organizations

Susan M. Abdel-Rahman, Michelle P. Wimes, Tom Curran

Summary: Individuals who identify as Black, indigenous, and people of color experience health disparities due to lack of empirical evidence for various treatments in their medical management. This paper proposes a new benchmarking strategy for evaluating racial and ethnic representation in clinical research, aiming to increase accountability for diversity and inclusion among organizations conducting clinical research.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Article Genetics & Heredity

Genomic answers for children: Dynamic analyses of > 1000 pediatric rare disease genomes

Ana S. A. Cohen, Emily G. Farrow, Ahmed T. Abdelmoity, Joseph T. Alaimo, Shivarajan M. Amudhavalli, John T. Anderson, Lalit Bansal, Lauren Bartik, Primo Baybayan, Bradley Belden, Courtney D. Berrios, Rebecca L. Biswell, Pawel Buczkowicz, Orion Buske, Shreyasee Chakraborty, Warren A. Cheung, Keith A. Coffman, Ashley M. Cooper, Laura A. Cross, Tom Curran, Thuy Tien T. Dang, Mary M. Elfrink, Kendra L. Engleman, Erin D. Fecske, Cynthia Fieser, Keely Fitzgerald, Emily A. Fleming, Randi N. Gadea, Jennifer L. Gannon, Rose N. Gelineau-Morel, Margaret Gibson, Jeffrey Goldstein, Elin Grundberg, Kelsee Halpin, Brian S. Harvey, Bryce A. Heese, Wendy Hein, Suzanne M. Herd, Susan S. Hughes, Mohammed Ilyas, Jill Jacobson, Janda L. Jenkins, Shao Jiang, Jeffrey J. Johnston, Kathryn Keeler, Jonas Korlach, Jennifer Kussmann, Christine Lambert, Caitlin Lawson, Jean-Baptiste Le Pichon, James Steven Leeder, Vicki C. Little, Daniel A. Louiselle, Michael Lypka, Brittany D. McDonald, Neil Miller, Ann Modrcin, Annapoorna Nair, Shelby H. Neal, Christopher M. Oermann, Donna M. Pacicca, Kailash Pawar, Nyshele L. Posey, Nigel Price, Laura M. B. Puckett, Julio F. Quezada, Nikita Raje, William J. Rowell, Eric Rush, Venkatesh Sampath, Carol J. Saunders, Caitlin Schwager, Richard M. Schwend, Elizabeth Shaffer, Craig Smail, Sarah Soden, Meghan E. Strenk, Bonnie R. Sullivan, Brooke R. Sweeney, Jade B. Tam-Williams, Adam M. Walter, Holly Welsh, Aaron M. Wenger, Laurel K. Willig, Yun Yan, Scott T. Younger, Dihong Zhou, Tricia N. Zion, Isabelle Thiffault, Tomi Pastinen

Summary: This study provided comprehensive diagnostic and candidate analyses for a pediatric rare disease cohort, achieving diagnostic rates ranging from 11% to 34.5%. HiFi long-read genome sequencing yielded increased discovery rate with more rare coding SVs. Variants and genes of unknown significance remained common in nondiagnostic cases.

GENETICS IN MEDICINE (2022)

Article Biochemistry & Molecular Biology

Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity

Taeju Park, Neka Large, Tom Curran

Summary: CrkL is more abundantly expressed than Crk in U-118MG cells, and both play essential overlapping roles in cell migration. Knockdown of CrkL leads to cell shrinkage and inhibits cell proliferation, adhesion, and invasion, while double knockdown of Crk and CrkL further enhances these effects.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

No Data Available